According to a new report LAMEA Artificial Intelligence in Diagnostics Market, published by KBV research, the LAMEA Artificial Intelligence in Diagnostics Market would witness market growth of 28.7% CAGR during the forecast period (2020-2026).
The Brazil market dominated the LAMEA Pathology Market by Country in 2019, thereby, achieving a market value of $1.6 Million by 2026. The Argentina market would witness a CAGR of 36.5% during (2020 - 2026). Additionally, The UAE market is experiencing a CAGR of 35% during (2020 - 2026).
The Software market dominated the Saudi Arabia Artificial Intelligence in Diagnostics Market in 2019, growing at a CAGR of 34.2 % during the forecast period. The Services market is poised to grow at a CAGR of 35.5% during (2020 - 2026). Additionally, The Hardware market is exhibiting a CAGR of 32.9% during (2020 - 2026).
The Neurology market dominated the South Africa Artificial Intelligence in Diagnostics Market by Diagnosis Type in 2019, growing at a CAGR of 33.7 % during the forecast period. The Oncology market is expected to witness a CAGR of 34.1% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/lamea-artificial-intelligence-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.
By Diagnosis Type
By Component
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
